SINA [SINA] CORRESP: (Original Filing)

[12TH FLOOR EAST TOWER | TWIN TOWERS | B-12 JIANGUOMENWAI DAJIE | BEIJING | 100022 WWW.SHEARMAN.COM | T +86.10.5922.8000 | F +86.10.6563.6000 RESIDENT PARTNERS Lee Edwards Ling Huang Alan D. Seem Admitted in New York Via Facsimile September 26, 2011 Ms. Kathleen Collins, Accounting Branch Chief Ms. Megan Akst Division of Corporation Finance 100 F Street, NE Re: SINA Corporation]

By | 2016-03-17T18:05:04+00:00 September 26th, 2011|Categories: Chinese Stocks, SEC Original, SINA|Tags: , , , , , |0 Comments

ONP [Orient Paper] 10-K/A: (Original Filing)

[EXPLANATORY NOTE This Amendment No. 2 to Form 10-K (this “Amendment”) amends the Annual Report for the period ended December 31, 2009 filed on March 29, 2010 (the “Original 10-K”) of Orient Paper, Inc. (the “Company”).] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Orient Paper, Inc. Science Park Nanhuan Road Xushui County Hebei Province 072550 China We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-150394) and Form S-3 (File No. 333-163340) of Orient Paper, Inc (the “Company”) of our reports dated September 26, 2011, relating to the] [SARBANES-OXLEY ACT OF 2002 I, Zhenyong Liu, certify that: 1. I have reviewed this annual report on Form 10-K/A of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [SARBANES-OXLEY ACT OF 2002 I, Winston C. Yen, certify that: 1. I have reviewed this annual report on Form 10-K/A of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: September 26, 2011 Zhenyong Liu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: September 26,2011 Winston C. Yen Chief Financial Officer (principal financial and accounting officer )]

NOAH [Noahs] 6-K: (Original Filing)

[NOAH HOLDINGS LIMITED Tao Thomas Wu Chief Financial Officer Noah Holdings Limited to Hold 2011 Annual General Meeting on November 3, 2011 Shanghai, September 22, 2011 No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will serve as an open forum for shareholders and beneficial owners of the Company’s American Depositary]

By | 2016-03-03T09:03:32+00:00 September 23rd, 2011|Categories: Chinese Stocks, NOAH, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] DEF 14A: (Original Filing)

[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: ______________________________________ (2) Aggregate number of securities to which transaction applies: ______________________________________ (3) (4) Proposed maximum aggregate value of transaction: ______________________________________ (5) Total]

By | 2016-03-03T12:31:32+00:00 September 23rd, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] CORRESP: (Original Filing)

[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 September 23, 2011 VIA EDGAR Ms. Tabatha Akins Staff Accountant Division of Corporation Finance 100 F Street, NE Re: China Pharma Holdings, Inc. Form 10-K for the fiscal year ended December 31, 2010 Filed March 3, 2011 and Amended March 17, 2011 Form 10-Q for]

By | 2016-03-03T19:01:30+00:00 September 23rd, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] CORRESP: (Original Filing)

[China Pharmas, Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 September 23, 2011 VIA EDGAR Ms. Tabatha Akins Staff Accountant Division ofrporation Finance 100 F Street, NE Re: China Pharmas, Form 10-K for the fiscal year ended December 31, 2010 Filed March 3, 2011 and Amended March 17, 2011]

By | 2016-02-07T22:43:07+00:00 September 23rd, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

NOAH [Noahs] 6-K: (Original Filing)

[NOAHS LIMITED Tao Thomas Wu Chief Financial Officer Noahs Limited to Hold 2011 Annual General Meeting on November3, 2011 STYLE="font-family:Times New Roman" SIZE="2"> Shanghai, September22, 2011 STYLE="font-family:Times New Roman" SIZE="2">No proposal will be submitted for shareholder approval at the annual general meeting. Instead, the annual general meeting will serve an open forum for shareholders and]

By | 2016-02-07T14:08:11+00:00 September 23rd, 2011|Categories: Chinese Stocks, NOAH, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] DEF 14A: (Original Filing)

[SCHEDULE 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies:______________________________________ (2)gregate number of securities to which transaction applies:______________________________________ (3) (4) Proposed maximumgregate value of transaction: ______________________________________]

By | 2016-02-07T16:05:56+00:00 September 23rd, 2011|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar